166 related articles for article (PubMed ID: 28928439)
21. [Effects of PNPLA3, TM6SF2 gene polymorphisms and its interactions with smoking and alcohol drinking on hepatitis B virus-associated hepatocellular carcinoma].
Wang LQ; Guo WH; Guo ZW; Qin P; Zhang R; Zhu XM; Liu DW
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Dec; 39(12):1611-1616. PubMed ID: 30572387
[No Abstract] [Full Text] [Related]
22. PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.
Wang P; Wu C; Li Y; Gong Y; Shen N
Gene; 2020 Jun; 742():144585. PubMed ID: 32173542
[TBL] [Abstract][Full Text] [Related]
23. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G
OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564
[TBL] [Abstract][Full Text] [Related]
24. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases.
Khlaiphuengsin A; Kiatbumrung R; Payungporn S; Pinjaroen N; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8377-82. PubMed ID: 26745088
[TBL] [Abstract][Full Text] [Related]
25. Correlation between the DEPDC5 rs1012068 polymorphism and the risk of HBV-related hepatocellular carcinoma.
Liu W; Ma N; Zhao D; Gao X; Zhang X; Yang L; Liu D
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):446-450. PubMed ID: 30683632
[TBL] [Abstract][Full Text] [Related]
26. Association between PNPLA3 gene polymorphisms and risk of hepatitis B virus-related hepatocellular carcinoma in Han population in China:a case-control study.
Gao X; Liu W; Yang L; Zhang X; Ma N; Wang L; Yan L; Tang L; Yang H; Liu D
Scand J Gastroenterol; 2017 Oct; 52(10):1120-1127. PubMed ID: 28617615
[TBL] [Abstract][Full Text] [Related]
27. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
[TBL] [Abstract][Full Text] [Related]
28. Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication.
Ohta A; Ogawa E; Murata M; Matsumoto Y; Yamasaki S; Ikezaki H; Furusyo N
J Med Virol; 2022 Oct; 94(10):5007-5014. PubMed ID: 35652276
[TBL] [Abstract][Full Text] [Related]
29. Soluble MICA and a MICA variation as possible prognostic biomarkers for HBV-induced hepatocellular carcinoma.
Kumar V; Yi Lo PH; Sawai H; Kato N; Takahashi A; Deng Z; Urabe Y; Mbarek H; Tokunaga K; Tanaka Y; Sugiyama M; Mizokami M; Muroyama R; Tateishi R; Omata M; Koike K; Tanikawa C; Kamatani N; Kubo M; Nakamura Y; Matsuda K
PLoS One; 2012; 7(9):e44743. PubMed ID: 23024757
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
31. PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication.
Miki D; Akita T; Kurisu A; Kawaoka T; Nakajima T; Hige S; Karino Y; Toyoda H; Kumada T; Tsuge M; Hiramatsu A; Imamura M; Aikata H; Hayes CN; Honda K; Seike M; Akuta N; Kobayashi M; Kumada H; Tanaka J; Chayama K
J Gastroenterol; 2020 Dec; 55(12):1162-1170. PubMed ID: 33057914
[TBL] [Abstract][Full Text] [Related]
32. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis.
Wang H; Cao H; Xu Z; Wang D; Zeng Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967497
[TBL] [Abstract][Full Text] [Related]
33. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
34. [Hepatitis C virus induced hepatocellular carcinoma associated genes].
Kato N; Muroyama R; Goto K
Nihon Rinsho; 2015 Feb; 73(2):333-8. PubMed ID: 25764692
[TBL] [Abstract][Full Text] [Related]
35. Disheveled EGL-10 and pleckstrin domain-containing 5 rs1012068 T/G gene polymorphism among Egyptian chronic HCV-infected patients: disease progression and related complications.
Farhan HM; Abougabal K; Gaber HF; Attia D
Egypt J Immunol; 2022 Jul; 29(3):36-43. PubMed ID: 35758967
[TBL] [Abstract][Full Text] [Related]
36. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
[TBL] [Abstract][Full Text] [Related]
37. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
Nakamura M; Kanda T; Nakamoto S; Miyamura T; Jiang X; Wu S; Yokosuka O
PLoS One; 2013; 8(12):e81312. PubMed ID: 24349054
[TBL] [Abstract][Full Text] [Related]
38. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
[TBL] [Abstract][Full Text] [Related]
39. PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.
Guyot E; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Beaugrand M; Charnaux N; Trinchet JC; Nahon P
J Hepatol; 2013 Feb; 58(2):312-8. PubMed ID: 23069476
[TBL] [Abstract][Full Text] [Related]
40. Identification of a functional variant in the MICA promoter which regulates MICA expression and increases HCV-related hepatocellular carcinoma risk.
Lo PH; Urabe Y; Kumar V; Tanikawa C; Koike K; Kato N; Miki D; Chayama K; Kubo M; Nakamura Y; Matsuda K
PLoS One; 2013; 8(4):e61279. PubMed ID: 23593449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
